What is EDETEK?
Founded in 2009, EDETEK has established itself as a critical provider of technology platforms and specialized clinical services. The company is best known for its proprietary COMFORM platform, which was introduced in 2016 to address systemic inefficiencies in clinical trial management. By focusing on data quality, accelerated completion timelines, and cost optimization, EDETEK serves as a vital partner for biotechnology and pharmaceutical firms navigating complex regulatory environments. Its global presence, spanning North America, Asia, and Europe, positions the company as a scalable enterprise solution provider capable of managing end-to-end clinical development workflows.
How much funding has EDETEK raised?
EDETEK has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in EDETEK
PPP
Public-Private Partnership
What's next for EDETEK?
With the recent infusion of capital, EDETEK is well-positioned to accelerate its product roadmap and enhance the capabilities of the COMFORM platform. The strategic focus will likely shift toward deepening its integration with emerging AI-driven data analytics to further reduce time-to-market for its clients. As the clinical research landscape becomes increasingly digitized, EDETEK's ability to maintain high data integrity while scaling operations will be paramount. Investors are closely monitoring the firm's capacity to capture additional market share in the enterprise clinical software space, particularly as demand for decentralized trial technologies continues to rise globally.
See full EDETEK company page
